The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...

The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...

The IPO (Initial Public Offering) of Sai Life Sciences Ltd (Sai Life), an emerging contract research, development and manufacturing organisation (CRDMO), is open for subscription at a critical ...

The IPO of Sai Life Sciences, which is backed by the global private equity major TPG Capital, was off to a decent start on December 11, the first day of subscription, as the issue was subscribed 66 ...

Sai Life Sciences IPO received an 84% subscription on Day 1, with QIBs subscribing 2.62 times and retail investors at 18%. The IPO will conclude on Friday.

Sai Life Sciences' initial public offering (IPO) was subscribed 84% on its first day. The Hyderabad-based company's Rs ...

About the issue Sai Life Sciences Ltd is preparing to launch its Initial Public Offering (IPO) for equity shares. Below are ...

Retail investors subscribed 8%, non-institutional investors 4%, while qualified institutional buyers made no bids yet for the ...

The promoters and promoter group hold an aggregate of 41.82% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 35.24%.

The ₹572-crore IPO of MobiKwik was subscribed over 26 times in retail category, followed by 7.5 times in NII segment.

Shares of Sai Life Sciences were trading at a premium of ₹28 in the grey market, at 4:30 PM on December 11, as per reports.